Advertisement

Advertisement

JP:4547 Stock Latest News

Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio

Company AnnouncementsKissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio

Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan

PremiumCompany Announcements

Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan

1M ago

Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout

PremiumCompany Announcements

Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout

2M ago

Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline

PremiumCompany Announcements

Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline

2M ago

Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss

PremiumCompany Announcements

Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss

2M ago

Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet

PremiumPre-EarningsKissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet

2M ago

Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids

Company Announcements

Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids

4M ago

Kissei Pharmaceutical initiated with a Neutral at UBS

The Fly

Kissei Pharmaceutical initiated with a Neutral at UBS

4M ago

Kissei Pharmaceutical Adjusts Dividend Payment Date

PremiumCompany Announcements

Kissei Pharmaceutical Adjusts Dividend Payment Date

4M ago

Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment

PremiumCompany Announcements

Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment

5M ago

Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook

PremiumCompany Announcements

Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook

5M ago

Kissei Pharmaceutical Reports Financial Results with Increased Net Sales

PremiumCompany Announcements

Kissei Pharmaceutical Reports Financial Results with Increased Net Sales

5M ago

Kissei Pharmaceutical Co (KSPHF) Q2 Earnings Cheat Sheet

PremiumPre-EarningsKissei Pharmaceutical Co (KSPHF) Q2 Earnings Cheat Sheet

5M ago

Kissei’s Linzagolix Gains Marketing Approval in Taiwan

Company Announcements

Kissei’s Linzagolix Gains Marketing Approval in Taiwan

6M ago

Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal

Company Announcements

Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal

6M ago

Kissei Pharmaceutical Completes Sale of Investment Securities

PremiumCompany Announcements

Kissei Pharmaceutical Completes Sale of Investment Securities

7M ago

Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan

PremiumCompany Announcements

Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan

8M ago

Kissei Pharmaceutical Revises Financial Forecast and Records Extraordinary Income

PremiumCompany Announcements

Kissei Pharmaceutical Revises Financial Forecast and Records Extraordinary Income

8M ago

Kissei Pharmaceutical Reports Q1 Financial Results with Increased Sales

PremiumCompany Announcements

Kissei Pharmaceutical Reports Q1 Financial Results with Increased Sales

8M ago

Is KSPHF a Buy, Before Earnings?

PremiumPre-EarningsIs KSPHF a Buy, Before Earnings?

9M ago

Kissei Pharmaceutical Completes Treasury Stock Disposal for Board and Officers

Company Announcements

Kissei Pharmaceutical Completes Treasury Stock Disposal for Board and Officers

9M ago

Kissei Pharmaceutical Expands TAVALISSE Launch to South Korea

Company Announcements

Kissei Pharmaceutical Expands TAVALISSE Launch to South Korea

9M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >